Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flu-IVIG Pilot Study
NCT02008578Phase 1Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Dec 2013
- Primary completion
- Jun 2014
- Modality
- IgG Antibodies, Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in influenza comparing Flu-IVIG with Placebo (2 arms). Primary endpoint: Hemagglutination Inhibition titer at 1 hour. Started Dec 2013; status: completed.
02
Drugs
FLU-IGIV
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02008578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02008578.